Theysohn, Jens M.
Demircioglu, Aydin
Kleditzsch, Malte
Ludwig, Johannes M.
Weber, Manuel
Umutlu, Lale
Li, Yan
Kircher, Malte
Lapa, Constantin
Buck, Andreas
Koehler, Michael
Wildgruber, Moritz
Lange, Christian M.
Palard, Xavier
Garin, Etienne
Herrmann, Ken
Forsting, Michael
Nensa, Felix
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 8 December 2021
Accepted: 24 November 2022
First Online: 1 December 2022
Competing interests
: J. M. Theysohn is active as a Boston Scientific consultant. No further financial or other relationship with any commercial organization that may have a direct or indirect interest in this manuscript exists. E. Garin is active as a Boston Scientific and Sirtex consultant. No further financial or other relationship with any commercial organization that may have a direct or indirect interest in this manuscript exists. K. Herrmann reports personal fees from Boston Scientific within the submitted work. K. Herrmann reports personal fees from Bayer, other from Sofie Biosciences, personal fees from SIRTEX, other from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants, personal fees from IPSEN, personal fees and non-financial support from Siemens Healthineers, non-financial support from GE Healthcare, outside the submitted work. All other authors have no financial or other relationship with any commercial organization that may have a direct or indirect interest in this manuscript.